Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM1 | Q13255 | 6/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1803701 | 0.90 | ALDH1A1 (0.42) | KMT2AALDH1A1ALOX15RAB9AEGFR | |
| SCHEMBL1804980 | 0.87 | KDM4E (0.45) | GRM1KMT2AALDH1A1TACR1RAB9A | |
| SCHEMBL20537201 | 0.84 | ALDH1A1 (0.47) | KMT2AALDH1A1RAB9A | |
| SCHEMBL1804359 | 0.83 | CYP1A2 (0.49) | KMT2AALDH1A1RAB9ACYP1A2CYP2C19 | |
| SCHEMBL27938010 | 0.82 | GPBAR1 (0.44) | GRM1KMT2ATACR1CYP1A2CYP2C19 | |
| SCHEMBL20536772 | 0.81 | ALDH1A1 (0.46) | KMT2AALDH1A1ALOX15 | |
| SCHEMBL21367353 | 0.81 | KMT2A (0.43) | GRM1KMT2ATACR1RAB9AKDM4E | |
| SCHEMBL123481 | 0.79 | GRM1 (0.41) | GRM1KMT2ATACR1RAB9AGRM5 | |
| SCHEMBL21965336 | 0.78 | CTNNB1 (0.42) | — | |
| SCHEMBL1802624 | 0.78 | ACLY (0.43) | KMT2AALDH1A1ALOX15RAB9AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3392236-B1 | METHOD FOR PRODUCING AROMATIC AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2021-06-23 | — | — | EP | disclosed |
| CN-108368030-B | Process for producing aromatic amide derivative | 三井化学AGRO株式会社 | 2020-09-18 | — | — | CN | disclosed |
| US-10647660-B2 | Method of producing aromatic amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2020-05-12 | — | — | US | disclosed |
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-20180362447-A1 | METHOD OF PRODUCING AROMATIC AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-12-20 | — | — | US | disclosed |
| EP-3392236-A1 | METHOD FOR PRODUCING AROMATIC AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2018-10-24 | — | — | EP | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | GRM1 247/4885KMT2A 1316/4885ALDH1A1 2424/4885 |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | GRM1 247/4885KMT2A 1316/4885ALDH1A1 2424/4885 |
| US-20180362447-A1 | METHOD OF PRODUCING AROMATIC AMIDE DERIVATIVE | HDHD5, NAAA, H1-4 | GRM1 4686/4885KMT2A 1774/4885ALDH1A1 461/4885 |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | GRM1 247/4885KMT2A 1316/4885ALDH1A1 2424/4885 |
| US-10647660-B2 | Method of producing aromatic amide derivative | HDHD5, NAAA, H1-4 | GRM1 4686/4885KMT2A 1774/4885ALDH1A1 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.